Literature DB >> 22192863

New hope for mobilization failures . . . again.

John F DiPersio1.   

Abstract

Mesh:

Substances:

Year:  2011        PMID: 22192863     DOI: 10.1016/j.bbmt.2011.12.578

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  2 in total

Review 1.  Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration.

Authors:  Erik De Clercq
Journal:  Antivir Chem Chemother       Date:  2019 Jan-Dec

2.  Safety and Effectiveness of Plerixafor for Peripheral Blood Stem Cell Mobilization in Autologous Stem Cell Transplantation: Results of a Post-Marketing Surveillance Study.

Authors:  Nobuhiro Tsukada; Momoko Nishikori; Hiroaki Goto; Rie Kanamori; Satoshi Nishina; Takashi Seto; Shinsuke Iida
Journal:  Drugs Real World Outcomes       Date:  2021-08-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.